CONTINUOUS GLUCOSE MONITORING SOLUTIONS Provided by Roche Diabetes Care

Transcription

1 CONTINUOUS GLUCOSE MONITORING SOLUTIONS Provided by Roche Diabetes Care More confidence for your patients

2 03 GIVING YOU THE CHOICE CGM solutions provided by Roche Diabetes Care Welcome to a world of new solutions for glucose measurement. Our CGM solutions enable your patients to live their life with confidence and peace of mind. They offer immediate and discreet access to glucose readings with accuracy you can trust and a wide range of possibilities to fit into your patient s lifestyle. Choose the option that is best for your patients.

3 04 05 ACCU-CHEK Insight CGM The Accu-Chek Insight CGM system features a patch sensor for convenient self-insertion. Ideal for patients with poor glucose control who want to start with CGM to improve therapy. The Eversense CGM system has a tiny implantable sensor that lasts up to 90 days. No need for weekly sensor changes and no sensor sticking through skin. Very accurate over 7 day period1 Highly sensitive during fluctuations and in low ranges2 Reliable alerts when high or low glucose levels are detected Easy and safe self-insertion Very accurate over the 90 day period3 Removable smart transmitter with on-body vibe alerts Predictive alerts before reaching low or high glucose level Simple, 5-minute in-office insertion

4 ACCU-CHEK Insight CGM ACCU-CHEK INSIGHT CGM The 7th sense that helps your patients get it right. Highly accurate CGM sensor Frequent rapid glycemic excursions and hypoglycemia New to CGM short term commitment to try CGM Flexibility of using a variety of insertion sites on the body 3 1 App for iphone / 2 Apple Watch compatibility / 3 Sensor Base Type of sensor base: Patch sensor base for 7 days of measurement Calibration: Two times a day Transmitter: Reusable transmitter; can be used up to one year after the first usage; waterproof App: For Apple ios devices, Android to follow Q1/2018 Data management: Accu-Chek Connect online portal, Accu-Chek Smart Pix system Wireless technology: BluetoothTM

5 08 3 EVERSENSE The first and only CGM with an implantable sensor that lasts up to 90 days Implantable Sensor / 2 Smart Transmitter / 3 App for Smartphone and Apple Watch Long lasting fully implanted sensor Removable and replaceable smart transmitter with on-body vibe alerts Gentle, fresh daily adhesive means fewer skin reactions Predictive low and high glucose alerts More information at: Type of sensor: Calibration: Transmitter: App: Implanted sensor lasts up to 90 days Two times a day Removable smart transmitter with on-body vibe alerts; rechargeable use for one year, water-resistant For Apple ios and Android devices Data management: Eversense Data Management System, Smart Pix 3.0, Diasend/Glooko Wireless technology: Bluetooth TM

6 10 11 My experience and I can only talk for myself I sensed no pain at all. Werner, Type 1; Using the Accu-Chek Insight CGM system 4 WHAT PATIENTS SAY I feel much more confident with the sensor, especially because I have fewer episodes of low blood glucose and that is super. I am totally free and can even better understand and control what goes on in my body! Linda, Type 1; Using the Accu-Chek Insight CGM system 4 Placing the sensor under the skin is not a major procedure. And it s less painful than pricking your fingertip six times a day. Wolfgang, Type 1; Using Eversense CGM Julia, Type 1; Using Eversense CGM

7 The company that offers you the choice in CGM. 1 Zschornack E Evaluation of performance of novel CGM J Diabetes Sci Technol Vol 7, Issue 4, July 20 2 Hinzmann et al. (2016) Analysis of the Accuracy and Performance of a Continuous Glucose Monitoring Sensor Prototype, Journal of Diabetes Science and Technology, Vol 11, Issue 3 3 Rodbard D. Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities, Diabetes Technology & Therapeutics, Vol 18, Supplement 2, Experiences from a study where a prototype of the Accu-Chek Insight CGM system was used. EVERSENSE is a trademark of Senseonics. ACCU-CHEK and ACCU-CHEK INSIGHT are trademarks of Roche. The Bluetooth TM word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. APPLE is a trademark of Apple Inc. ANDROID is a trademark of Google Inc. All other product names and trademarks are the property of their respective owners Roche Diabetes Care. All rights resevered Roche Diabetes Care GmbH Sandhofer Straße Mannheim